Join
Live feed
·
PRReleasevia Quantisnow
SpyGlass Pharma Inc. logo

SpyGlass Pharma Announces Positive Topline 12-Month Phase 1/2 Trial Results for Its Innovative BIM-IOL System

ByQuantisnow·Wall Street's wire, on your screen.
SGP· SpyGlass Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SGP (SpyGlass Pharma Inc.) and more on Quantisnow.